Cargando…
A genetic map of the chromatin regulators to drug response in cancer cells
BACKGROUND: Diverse drug vulnerabilities owing to the Chromatin regulators (CRs) genetic interaction across various cancers, but the identification of CRs genetic interaction remains challenging. METHODS: In order to provide a global view of the CRs genetic interaction in cancer cells, we developed...
Autores principales: | Chen, Bo, Li, Pengfei, Liu, Mingyue, Liu, Kaidong, Zou, Min, Geng, Yiding, Zhuang, Shuping, Xu, Huanhuan, Wang, Linzhu, Chen, Tingting, Li, Yawei, Zhao, Zhangxiang, Qi, Lishuang, Gu, Yunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523919/ https://www.ncbi.nlm.nih.gov/pubmed/36180906 http://dx.doi.org/10.1186/s12967-022-03651-w |
Ejemplares similares
-
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
por: Zhuang, Shuping, et al.
Publicado: (2021) -
Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma
por: Liu, Kaidong, et al.
Publicado: (2022) -
Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer
por: Li, Yawei, et al.
Publicado: (2021) -
Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome
por: Dong, Qi, et al.
Publicado: (2021) -
Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells
por: Liu, Mingyue, et al.
Publicado: (2023)